CytoDyn (CYDY) Earnings Date, Estimates & Call Transcripts → Urgent dollar warning (From Stansberry Research) (Ad) Free CYDY Stock Alerts $0.14 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share EarningsStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Earnings SummaryLatest Earnings DateApr. 15EstimatedActual EPS (Apr. 15) -$0.01 Missed By -$0.01 Get CytoDyn Earnings AlertsEnter your email address below to receive the latest news and earnings results for CYDY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCYDY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CYDY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. CYDY Earnings Date and InformationCytoDyn last posted its quarterly earnings results on April 15th, 2024. The biotechnology company reported ($0.01) EPS for the quarter. CytoDyn has generated ($0.05) earnings per share over the last year (($0.05) diluted earnings per share). Read More CytoDyn Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript4/15/2024Q3 2024-($0.01)($0.01)($0.01)--1/16/2024Q2 2024-($0.01)($0.01)($0.01)--10/23/2023Q1 2024-($0.01)($0.01)($0.01)--9/13/2023Q4 2023-($0.02)($0.02)($0.02)--4/10/2023Q3 2023-($0.02)($0.02)($0.02)--1/9/2023Q2 2023-($0.03)($0.03)($0.03)-- Get the Latest News and Ratings for CYDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter. 10/11/2022Q1 2023-($0.03)($0.03)($0.03)--4/11/2022Q3 2022-($0.05)($0.05)($0.05)--10/12/2021Q1 2022-($0.05)($0.05)($0.05)-$0.04 million7/30/2021Q4 2021-($0.08)($0.08)($0.08)-- CytoDyn Earnings - Frequently Asked Questions When did CytoDyn announce their last quarterly earnings? CytoDyn (OTCMKTS:CYDY) last announced its quarterly earning data on Monday, April 15, 2024. Learn more on CYDY's earnings history. How much revenue does CytoDyn generate each year? CytoDyn (OTCMKTS:CYDY) has a recorded annual revenue of $270,000.00. How much profit does CytoDyn generate each year? CytoDyn (OTCMKTS:CYDY) has a recorded net income of -$79.82 million. CYDY has generated -$0.05 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: CRVO Earnings Date RGLS Earnings Date CAPR Earnings Date CYBN Earnings Date IXHL Earnings Date SYRS Earnings Date AEON Earnings Date SGMT Earnings Date PRQR Earnings Date AMLX Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: PayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting Season This page (OTCMKTS:CYDY) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoDyn Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.